Latest News

Keep up to date with all our latest investments, service offerings and news items.

Click here to view our latest media kit

  • January 18, 2018

    Almac Group announces further expansion at its European Campus in Dundalk

  • January 5, 2018

    Stunning Science Success Celebrated

  • December 8, 2017

    Young people presented with accredited awards at celebration event

  • December 5, 2017

    Almac Group Receives Annual Industrial Award from the Institute of Chemistry of Ireland

  • December 4, 2017

    Almac Discovery publishes USP7 inhibitors from UbiPlexTM Platform

  • November 13, 2017

    Almac Clinical Technologies’ President & Managing Director Keynotes Life Sciences PA’s CRO & CMO Summit

  • November 6, 2017

    Almac Group Enters Strategic Partnership with W5

  • November 2, 2017

    Almac Group’s US Financial Controller Appointed to Irish American Business Chamber & Network (IABCN)’s Board of Directors

  • November 1, 2017

    Veeva Systems Inc.: Veeva Announces Partner Approach for Best-in-Class Randomization and Trial Supply Management

  • November 1, 2017

    Almac Group Announces Acquisition of BioClin Laboratories

  • October 24, 2017

    Almac Group Introduces Accountability and Reconciliation Tracking

  • October 24, 2017

    Arran Chemical Company Completes First Phase of its Three Part Strategic Plan “ADAPT”

  • October 23, 2017

    Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment

  • October 23, 2017

    Almac Group Announces Successful MHRA Inspection at Charnwood Facilities

  • October 18, 2017

    The Search is on for ‘Northern Ireland’s Top Science Students

  • October 16, 2017

    Almac Pod™ – Changing the Global Dynamics of Temperature Controlled Shipping Solutions

  • October 16, 2017

    Hurricane Ophelia: Almac Group Update

  • October 6, 2017

    Almac Group Wins Export Achievement Award at the Pharma Industry Awards

  • September 13, 2017

    Almac Group Leads Economic Growth in Pennsylvania and the U.S.

  • September 4, 2017

    Almac Discovery Announces ALM201 Poster Presentation at 2017 European Society for Medical Oncology Congress

  • August 10, 2017

    Almac Group Announces US Workshops Targeting EU Product Launch Best Practices

  • August 10, 2017

    “Portadown Gets Active” A scheme to support local children and end holiday hunger

  • August 7, 2017

    High-demand IT skills being developed at innovative summer camp

  • July 3, 2017

    Almac Discovery is Granted Orphan Drug Designation for ALM201 Programme in Ovarian Cancer

  • July 3, 2017

    Lismore Comprehensive Represents Northern Ireland in Young Enterprise UK final

  • June 30, 2017

    Petya ransomware attack – Almac update

  • June 23, 2017

    Almac Group scoops top prize at Made in the UK Awards

  • June 20, 2017

    Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor

  • June 19, 2017

    Almac Group Recognised as a Top 50 Company for Transatlantic Operations

  • June 13, 2017

    Almac Group Awarded U.S. Patents for Ground-breaking “DDRD” Assay

  • June 8, 2017

    Almac Group Reports Pre-tax Profits of £27M

  • May 16, 2017

    Almac Group Executives Share Expertise at Upcoming Industry Conferences

  • May 8, 2017

    Almac Discovery Announces key Wee-1 kinase patent approval

  • April 20, 2017

    Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation

  • March 15, 2017

    Almac to Exclusively Share Global Expertise in EU Product Launch Workshop

  • March 14, 2017

    Almac Group Executives Share Expertise at Key Industry Events

  • March 8, 2017

    Almac Diagnostics and EORTC Establish Collaboration for Tumour Molecular Profiling

  • February 28, 2017

    Irish Ambassador to US will present distinguished awards to Beneficial Bank, Eileen McDonnell, and Sean Rooney

  • February 22, 2017

    Almac Group Hosts Official Visit by British Deputy Consul General

  • February 16, 2017

    Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations

  • February 14, 2017

    RCSI and Almac Discovery enter research collaboration to target therapy-resistant cancer tumours

  • January 30, 2017

    Almac Group Launches Next Generation Temperature Management Software

  • January 26, 2017

    Almac Group Announces Further Global Expansion as it Secures New Premises in Republic of Ireland

  • January 12, 2017

    Almac Group Executive to Speak at IQPC Clinical Trial Supply Europe 2017

  • January 9, 2017

    Almac Group Launches Almac Clinical University

  • December 15, 2016

    Almac Group Collaborates with Exostar to Extend Clinical Trials Identity Management

  • December 13, 2016

    Almac Group Appoints Professor Tom Moody as VP of Technology Development and Commercialisation

  • December 12, 2016

    Almac Group Trio are Masters of Work and Study

  • December 6, 2016

    Almac Group Announces Strategic Partnership with inVentiv Health

  • November 28, 2016

    Almac Group Executive to Speak at CTS East Asia Conference

  • November 17, 2016

    Almac Group Team Up with Irish American Business Chamber & Network for Life Sciences Forum

  • November 14, 2016

    Almac Group Expands Commercial Capabilities to Meet Industry Demand for Paediatric Formulations

  • November 10, 2016

    Almac Group Announce £27 million Global Expansion

  • October 28, 2016

    Almac Group Appoints Dr. Victor Diaz Perez as Head of Physical Sciences

  • October 18, 2016

    Almac Group’s Temperature Management Software Solution Receives Innovation Award

  • October 14, 2016

    Almac Group Wins Prestigious Research and Development Award

  • October 10, 2016

    Almac Group Discover an Exciting Link between its Immune Response Assay and Checkpoint Inhibitor Based Therapy

  • October 4, 2016

    Almac Diagnostics Partner with ArcherDX

  • September 20, 2016

    Almac Group Celebrates 20 Years in North America with $5.2 million Expansion Creation of 79 Additional Jobs in North Carolina

  • August 8, 2016

    Almac Publish Second Validation of Stage II Colon Cancer Recurrence Assay in the Journal of Clinical Oncology

  • August 2, 2016

    Almac Group’s Integrated Development to Commercialisation Services Support Amicus Therapeutics’ First Commercial Orphan Drug Product

  • July 14, 2016

    Almac Group’s Rapid Launch Services Support U.S. Approval of Intercept Pharmaceutical’s First Commercial Orphan Drug Product

  • June 14, 2016

    Successful Inspection by FDA of Almac Clinical Services North Carolina Facility

  • June 8, 2016

    Almac Diagnostics Expand Companion Diagnostic Development Service Offering with NanoString Barcoding Technology

  • June 2, 2016

    Almac Appoints New Vice President of Corporate Marketing

  • May 30, 2016

    Almac Discovery, McClay Foundation and Ulster University join forces to explore diseases of the eye

  • May 23, 2016

    Almac to partner with ZYMtronix to deploy its universal enzyme immobilisation platform

  • May 9, 2016

    The Almac Pod™ – Changing the Dynamics of Temperature Controlled Shipping Solutions

  • April 25, 2016

    Almac Clinical Technologies Announces Participation in the Avoca Diligent Prequalification Platform

  • April 25, 2016

    Almac Group Launches US Serialisation Solution in Partnership with Optel Vision

  • March 23, 2016

    Almac Wins Three CMO Leadership Awards

  • March 8, 2016

    Almac Group Opens Additional Companion Diagnostic Laboratory in Durham NC USA

  • March 2, 2016

    Almac Group Win Irish American Business Chamber Award in USA

  • February 4, 2016

    Almac Discovery Secures Patent Protection for Novel allosteric Akt inhibitor (ALM301)

  • January 25, 2016

    NEW Fluorescence Lifetime Platform Unveiled at SLAS

  • November 12, 2015

    Almac Group to Collaborate with Illumina on Next-Generation Sequencing Based Companion Diagnostic Development

  • November 9, 2015

    Almac Group announces significant expansion in pharmaceutical development capacity

  • November 3, 2015

    Almac Acquires Arran Chemical Company and Expands Biocatalysis Services

  • October 12, 2015

    Industry’s Newest Generation IRT Fuels Growth of Almac Group’s Business

  • October 7, 2015

    Almac Group Addresses Industry Demand for Multiparticulate Drug Products with Scalable Fluid Bed and Encapsulation Technologies

  • October 5, 2015

    Almac Discovery Secures European Patent Protection for ALM201

  • September 9, 2015

    Almac Group’s Integrated CMC Services Support US Approval of Wellstat Therapeutics’ First Commercial Orphan Drug Product

  • September 7, 2015

    Almac Group’s Asia Pacific Headquarters Receives Official Health Science Authority (HSA) Accreditation

  • September 7, 2015

    Almac Group Expands Clinical Trial ‘Direct to Patient’ Service throughout Europe

  • July 10, 2015

    Almac Group Expands Asia Pacific Presence with New Regional Headquarters and Clinical Trial Supply Facility in Singapore

  • July 10, 2015

    Almac Group Appoints New Vice President of Global Business Development

  • July 10, 2015

    Almac Group Appoints Dr. John Robson as VP Quality Operations

  • July 10, 2015

    Almac Group Announce Companion Diagnostic Partnerships with OncoMed

  • July 10, 2015

    Almac Discovery Announce Ubiquitin Specific Protease Collaboration with Genentech

  • July 10, 2015

    Almac Group Named UK Trade & Investment Winner in Final of the European Business Awards 2014/5

  • March 3, 2015

    Almac Group Appoints Dr. Shirin Khambata Ford as VP Product Development

  • February 5, 2015

    Almac Group Drives Biocatalysis Leadership with a Further $7M Investment

  • February 5, 2015

    Almac Appoints VP Quality and Regulatory Affairs

  • December 8, 2014

    Almac Crowned overall Ulster Bank Business Achiever

  • November 26, 2014

    Almac raises £9,000 for ovarian cancer charity in memory of employee

  • November 5, 2014

    Almac continues winning streak at Irish Pharma Industry Awards 2014

  • October 21, 2014

    Almac’s PATHWAY™ Points Students in Right Direction for STEM Careers

  • October 20, 2014

    Almac Introduce Flexible Clinical Trial Direct to Patient Solution

  • July 10, 2014

    PA Governor Tom Corbett Praises Almac during Visit

  • June 5, 2014

    Almac Launches Recruitment Drive to Fill up to 20 New Positions

  • May 27, 2014

    Almac sees profits increase by 30% as company enjoys record year

  • May 1, 2014

    Almac flies high at Aer Lingus Viscount Awards

  • March 28, 2014

    Almac Achieves Double Success at Business Award Ceremony

  • March 11, 2014

    Almac Expands Asia Pacific Operations, Establishes Regional Operations Center in Singapore

  • January 28, 2014

    Data Presented Supporting Almac Developed Colon Signature as a Significant Predictor of Risk of Recurrence in Stage II Colon Cancer

  • January 21, 2014

    Almac publishes breast cancer chemotherapy response assay in the Journal of the National Cancer Institute

  • December 10, 2013

    Almac wins Laboratory Team of the Year at The Irish Laboratory Awards 2013

  • November 26, 2013

    Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer

  • November 18, 2013

    Almac Further Enhance 3rd Party Logistics Commercial Support Services for Niche / Orphan Drugs

  • November 13, 2013

    Almac’s Strengthened Facilities Accommodates Demand of Late Stage API Manufacture

  • November 5, 2013

    Almac Increase Global Stability Storage Capacity

  • October 29, 2013

    Richard Segiel, Jr. Joins Almac as Vice President of US Business Development

  • October 23, 2013

    Almac invests to accelerate formulation development services

  • October 22, 2013

    Almac expands US & UK commercial facilities

  • October 22, 2013

    Novozymes Biopharma announces collaboration with Almac in Drug Manufacture, Half Life Extension and Targeting Technologies

  • October 7, 2013

    Almac Launches New [14C]-labelled ADCs Service Offering

  • September 23, 2013

    Almac Launches SupplyTraQ™ Technology Solution to Streamline Clinical Trial Supply Administration

  • September 19, 2013

    Almac Launches Reusable Shipper Option for Temperature-Controlled Distribution

  • September 10, 2013

    Almac Offering TruSight Tumor Profiling Next-Generation Sequencing Service

  • September 4, 2013

    Almac/Queen’s Announce Cancer Research Initiatives Representing £13 Million Investment

  • July 31, 2013

    Almac Receives Appreciation Award from Otsuka America Pharmaceutical, Inc.

  • July 2, 2013

    Almac Introduce Contained Drug Handling and Bottling Capabilities in EU and US Clinical Services Sites

  • June 11, 2013

    ALMAC ANNOUNCES FURTHER EXPANSION AND 229 NEW JOBS

  • June 7, 2013

    Almac Employees Reward Macmillan Belfast, Mindwise Lurgan and Craigavon’s Neonatal Unit in Annual Charity of Choice Survey

  • May 15, 2013

    Almac secures new metagenomics and enzyme discovery programme with UCL

  • April 26, 2013

    You don’t need to wear a lab coat to work at Almac!

  • February 20, 2013

    Almac Receives FDA Inspection Approval

  • February 18, 2013

    Almac and DSM Collaboration Agreement in Biocatalysis Continues with Success

  • February 13, 2013

    Almac to deliver insight into Supply Chain Management at Clinical Trial Supply Europe Event

  • February 6, 2013

    Almac launches US commercial packaging operations with successful FDA inspection and new client partnership

  • January 21, 2013

    Almac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade

  • January 14, 2013

    Almac Doubles Drug Product Development Capacity with a New Non-GMP Facility

  • January 7, 2013

    Almac and TTP Labtech form alliance in fluorescence lifetime technology

  • December 12, 2012

    Charlie Morris Appointed to Almac’s Clinical Technologies Executive Team

  • November 16, 2012

    Almac’s Early Christmas Present to Local Cancer Charity

  • November 7, 2012

    Recycling works: Almac’s new environment initiative saves £72,000 per year

  • October 10, 2012

    Almac increase early phase ‘hit to lead’ chances with Pre-Clinical Screening Packages

  • October 9, 2012

    Almac Concludes Commercial API Manufacturing Facility Expansion Plans

  • October 8, 2012

    Almac and DSM Sign Collaboration Agreement in Biocatalysis

  • October 3, 2012

    Almac expands UK commercial capacity with the acquisition of new blistering technology

  • September 26, 2012

    Successful MHRA Inspection of Almac’s Clinical Services UK Facility

  • September 17, 2012

    Almac Launches New Histone Reagents Catalogue and Custom Synthesis Service

  • August 21, 2012

    Almac announces launch of Next Generation Sequencing service for personalised medicine

  • August 8, 2012

    Almac Streamline Temperature Sensitive Clinical Supplies with Enhanced Service Offering

  • July 18, 2012

    US Consul General applauds Almac’s economic contribution to the US pharmaceuticals market

  • July 2, 2012

    Almac launches mobile website in response to large mobile user base

  • June 13, 2012

    Almac Introduces Qualified Person Facilitation Program

  • June 11, 2012

    Almac and VTU Technology form collaboration to provide customers with high yielding, fast-track generation of site-specific modified products

  • May 14, 2012

    Almac Adds High-Speed Clinical Trial Blistering Equipment at US HQ

  • May 1, 2012

    Almac installs Uhlmann Blister Line in new US Commercial Packaging Facility

  • April 26, 2012

    Almac Rewarded for Excellence in Technology

  • April 4, 2012

    Almac reports progress in Clinical Technologies Lean Six Sigma Efforts

  • March 29, 2012

    Almac and Affymetrix Announce a Global Distribution Agreement for Almac’s Xcel™ Array

  • March 15, 2012

    Almac’s Clinical Trial Workshop Series to return in 2012

  • March 15, 2012

    Almac and SRC to boost training for science careers

  • March 12, 2012

    Almac adds aXcess™ to its suite of services to complement clinical packaging and distribution bundle

  • March 7, 2012

    Almac expands in US with addition of Commercial Packaging facility in Audubon

  • February 28, 2012

    Almac Boosts Capacity and Productivity with Acquisition of New Encapsulation Equipment

  • February 13, 2012

    selectAZyme™ grows into metabolite synthesis

  • February 9, 2012

    One Year On…Almac Doubles Analytical Capacity in US Headquarters

  • February 1, 2012

    Almac announce launch of Next Generation Sequencing (NGS) Data Analysis Services

  • January 23, 2012

    Almac Celebrates MHRA Audit Successes

  • January 17, 2012

    MGB Biopharma and Almac Collaborate on Contract Manufacturing Project

  • January 11, 2012

    Almac strengthens Board with appointment of new Financial Director

  • January 9, 2012

    New building will help Almac serve customers from Argentina to Zimbabwe

  • November 30, 2011

    Almac’s Diagnostic Laboratory Receives Accreditation from College of American Pathologists

  • November 29, 2011

    Almac extends helping hand to local charities

  • November 28, 2011

    Almac Shines At Awards Ceremonies

  • November 21, 2011

    Almac Responds to Alexion’s Request for Rapid Packaging and Distribution During Public Health Crisis in Germany

  • November 17, 2011

    Co Tyrone woman is Almac’s 2,000th UK employee

  • November 8, 2011

    Almac publishes Stage II colon cancer recurrence signature in the Journal of Clinical Oncology

  • October 25, 2011

    Almac’s rapidd continuing to accelerate early stage development 2 years on

  • October 24, 2011

    Almac Invests in New Commercial API Manufacturing

  • October 21, 2011

    Almac Invests £1M in Dedicated Mass Spectrometry Laboratory

  • October 20, 2011

    Almac Announces Expansion of Pharmaceutical Development Facilities

  • October 5, 2011

    Almac and Greenphire Form Alliance to Deliver Direct-to-Patient Stipend Payments Through IXRS®

  • September 23, 2011

    Almac flies the flag for European Day of Languages

  • September 8, 2011

    Almac takes a clinical approach – Almac CEO Alan Armstrong talks about the firm’s continuing expansion

  • September 7, 2011

    Almac-Queen’s cancer expert to lead £4.4m collaboration

  • July 19, 2011

    Almac wins ‘The American Society for Quality’ Award in Philadelphia

  • July 4, 2011

    Almac to perform the analytic phase of AclarusDx™ for Exonhit

  • June 30, 2011

    Almac Expands Global Coverage by Adding Depots for Clinical Trial Supply Distribution to the Asia Pacific Region

  • June 17, 2011

    Almac to Feature New Enhancements to its Integrated Supply Chain Management and Patient Compliance Services at the Annual DIA Meeting in Chicago

  • May 31, 2011

    Almac data to be presented at annual ASCO meeting

  • May 20, 2011

    Almac celebrate official opening of North American HQ with former US. Senator George Mitchell

  • May 11, 2011

    Almac to host inaugural European Product Launch workshop for US Biopharmaceutical Companies

  • May 6, 2011

    Todd Kole Appointed to Almac’s Clinical Technologies Executive Team

  • May 4, 2011

    Almac Introduces selectAZymeTM

  • April 13, 2011

    Almac wins 2011 Northern Ireland Business of the year accolade

  • April 7, 2011

    Northgate Managed Services Delivers Seamless Transfer to Almac’s New US HQ

  • March 30, 2011

    Almac open CLIA lab for biomarker clinical trials

  • March 28, 2011

    BioFocus and Almac collaborate to offer fluorescent lifetime assays

  • March 25, 2011

    Almac announces expansion to its commercial facility with the addition of increased storage capacity for biologic products

  • March 23, 2011

    Almac to Demonstrate New Patient Management Services at the Euro DIA and Partnerships in Clinical Trials Conferences

  • March 16, 2011

    The A to ZED of Automated Walleting for clinical trial supply

  • March 1, 2011

    Live Webinar March 28th: An Integrated Approach to Biomarker Discovery

  • February 28, 2011

    Almacs New Headquarters Takes Control of Scheduled I-V Substances Capabilities

  • February 17, 2011

    Almac announce Launch of Bioinformatics Consultancy

  • February 14, 2011

    Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference

  • February 7, 2011

    Almac Opens Analytical Labs in New US Headquarters

  • January 19, 2011

    Distribution Heats Up as Almac Continues its Transition to New North American Headquarters

  • December 16, 2010

    Almac wins News Flow of the Year Category at the Genesis 2010 Awards

  • November 26, 2010

    Almac adds Late Stage Customisation Suite to assist Orphan Drug / Niche Product Launches into Europe

  • November 23, 2010

    Almac discusses its investment in biocatalysis lauding cost and environmental benefits on OutsourcingPharma.com

  • November 19, 2010

    Almac and the Royal Society of Chemistry host a workshop on the use of analytical techniques to control and monitor solid form

  • November 10, 2010

    Almacs Clinical Technologies Business Unit Again Receives `Best Places to Work in PA 2010′ Award

  • October 18, 2010

    Almac has Successful MHRA Inspection at its Clinical Services UK Site

  • October 13, 2010

    Almac Successfully Moves its Clinical Technologies Business Unit into New North American Headquarters

  • October 7, 2010

    Almac continues biocatalysis business growth with a further $4m R&D investment

  • October 4, 2010

    Almac ‘Event in the Tent’ raises £14,500 for Charities

  • October 4, 2010

    Almacs North American Headquarters Opens Its Doors for Audits

  • September 21, 2010

    Almacs Clinical Technologies Division undergoes successful joint GCP-GMP MHRA Inspection

  • September 20, 2010

    Almac One Step Closer to Completion of U.S. Headquarters Buildings

  • September 3, 2010

    View our Client Message Regarding New North American Headquarters

  • August 26, 2010

    Almac Discusses New Biomarker Service on OutsourcingPharma.com

  • August 2, 2010

    Almac launch Biomarkers for biopharma

  • July 9, 2010

    Bill Kane Joins Almac as Director of Quality Assurance and Regulatory Compliance

  • July 7, 2010

    Almac supports Queens University “oncology hub” with new McClay library

  • June 28, 2010

    Almac Announces Collaboration with Aeterna Zentaris to Develop Therapy and Companion Diagnostic in Cancer

  • June 23, 2010

    Special Recognition Accolade posthumously awarded to Sir Allen McClay, Founder of Almac

  • June 21, 2010

    Almac’s US Headquarters will Address Capacity Demand for Clinical Supplies

  • June 14, 2010

    Almac completes £2 million client sponsored investment expanding commercial sacheting capacity

  • June 11, 2010

    Almac to feature Expert Speakers at Upcoming DIA Annual Meeting

  • June 9, 2010

    Almac Announces Launch of IXRS® 2.0 Next Generation Clinical Technology

  • June 3, 2010

    Almac Launch Xcel Array – the Optimum Platform for Biomarker Discovery

  • May 26, 2010

    Almac wins UK Great Place to Work award

  • May 12, 2010

    Almac and University College Cork announce launch of academic/industrial collaboration

  • May 5, 2010

    Almac’s North Carolina Facility Continues Growth in Academically based Clinical Trials

  • April 29, 2010

    Almac extends Site-specific PEGylation Technology to single domain antibodies

  • April 22, 2010

    Almac Announces Environmentally-Friendly Features

  • April 21, 2010

    Graham Nicholls Joins Almac as Director of Biostatistics

  • April 19, 2010

    Almac completes its expansion plan to Pharma Services facilities

  • April 15, 2010

    Almac Group Finds Pharmony With New Website

  • April 12, 2010

    Almac partners with Merck KGaA and the MRC to assess markers of response to Cetuximab therapy

  • April 8, 2010

    Almac Clinical Technologies Releases Almac Interactive Reporting for IXRS

  • April 7, 2010

    Almac wins Excellence in Innovation Category at Tenth Annual Belfast Telegraph / BMI Northern Ireland Business Awards – Read more.

  • April 7, 2010

    New FLEXYTE® Protease Assays Enable Information-rich Output, Miniaturization and Multiplexing

  • April 1, 2010

    Almac to Improve Label Approval Process in Clinical Trials

  • March 17, 2010

    Almac and Queens University Belfast showcase Northern Irish ‘oncology hub’ to senior Washington DC delegates

  • March 8, 2010

    Almac wins prestigious Aer Lingus Viscount Award for Overall Excellence

  • March 5, 2010

    Successful Inspection by FDA of Almac Clinical Services North Carolina Facility

  • February 26, 2010

    Almac Expands Radiolabelling Facilities to Include 14C API and IMP Supply

  • February 17, 2010

    Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials

  • February 10, 2010

    Almac adds Xcelodose® 600S Precision Powder Micro-dosing System to its Product Development Capabilities

  • January 18, 2010

    Almac Announces that AstraZeneca is to Undertake Evaluation FLEXYTE Protein Kinase Assays

  • January 13, 2010

    Statement on the Sad Death of Sir Allen McClay

  • December 7, 2009

    Almac Clinical Technologies Announces Patient-Reported-Outcomes Partnership with FACIT.org

  • December 1, 2009

    Bioinformatics Expansion Heralds Further Growth for Almac

  • November 16, 2009

    Almac Doubles Capacity at North Carolina Facility

  • November 10, 2009

    Almac to Speak at Upcoming CDISC Interchange with Technology Partners

  • November 2, 2009

    Almac Launches Unique Site-specific PEGylation Technology at BIO Europe

  • October 15, 2009

    Almac Announce Potent Containment Capabilities

  • October 14, 2009

    Almac Extends Commercial Support Services to add Third Party Logistics “3PL”

  • October 14, 2009

    “rapidd” Accelerating Early Stage Development, Minimising Cash Burn

  • October 13, 2009

    US Labs will Extend Analytical and Solid State Support

  • October 13, 2009

    Almac and Edinburgh Instruments launch of FLEXYTE fluorescence lifetime assays at MipTec

  • October 9, 2009

    Almac staff raise £9,000 for local charities

  • October 1, 2009

    Almac Clinical Technologies Named One of the ‘Best Places to Work in PA 2009’

  • September 29, 2009

    Almac Secures Room to Grow; Plans Expected to Lead to 500 Jobs

  • September 15, 2009

    Almac and Lilly Partner on Companion Diagnostic Development

  • September 2, 2009

    Establishment of McClay Foundation Marks New Era for Northern Ireland

  • July 28, 2009

    UM Breast Cancer Researchers partner with Almac to win prestigious Department of Defense Grant

  • July 21, 2009

    MHRA Grants Almac IMP License for its Radiolabelling Service

  • July 15, 2009

    Almac Group Continues Aggressive Hiring Campaign in PA to Meet Growing Demand from Pharma and Biotech Customers

  • July 9, 2009

    Official opening of Almac Diagnostics headquarters

  • June 30, 2009

    Almac Completes Phase 1 of its Expansion Plan to Pharma Services Facilities

  • June 17, 2009

    Almac to Showcase Integrated Clinical Trial Solutions at 45th Annual DIA Meeting

  • June 2, 2009

    Almac and Middlebrook Pharmaceuticals discuss their successful partnership in Tablets and Capsules

  • May 18, 2009

    Almac Announces Collaboration with Pfizer and the PETACC3 Translational Research Working Party

  • May 15, 2009

    Almac Event Proves Engineers Make It Happen

  • April 29, 2009

    Dr Tanney Discusses Challenges Faced in Fine Tuning Sample Preparation Techniques

  • April 27, 2009

    Minister Praises Craigavon Life Sciences Firm’s Commitment To Research and Development

  • April 23, 2009

    Almac Launches Biocatalyst Kits

  • April 23, 2009

    Almac and PHT Announce Formal Alliance to Improve Clinical Trial Data Quality

  • April 6, 2009

    Almac – `Business of the Year Award is Company Milestone’

  • April 6, 2009

    Almac Group Uses HP Technology to Bring New Drugs to Market Faster

  • March 19, 2009

    Almac Showcases ePRO Technology at 21st DIA EuroMeeting

  • March 18, 2009

    Almac Tops Off New North American Headquarters

  • March 10, 2009

    Almac Collect Top Recognition for New Ovarian Cancer Research Product

  • March 5, 2009

    Almac Win “Exporter of the Year” in Economic Awards

  • February 24, 2009

    Almac Completes First Paperless Client Audit

  • February 13, 2009

    Almac Continues Global Expansion of Clinical Supply Services with Huge Facility for Specialist Storage

  • February 5, 2009

    Almac Jobs Boost for Northern Ireland

  • February 5, 2009

    Almac Pharma Services Retained by MiddleBrook Pharmaceuticals to Produce Physician Samples of MOXATAG

  • January 29, 2009

    Almac Promotes Biocatalysis and Radiolabeling

  • January 29, 2009

    Almac Launches Solid State Services

  • January 26, 2009

    Intelligroup Secures Multi-Million Dollar COSMOS Implementation with Almac Clinical Services

  • January 19, 2009

    Key Almac division celebrates 20 years of growth

  • January 8, 2009

    Almac Selects NuGEN Ovation® Systems to Broaden Gene Expression

  • January 7, 2009

    Almac Clinical Technologies Expands Yardley, PA Headquarters

  • January 6, 2009

    Almac Growth Continues Into 2009

  • December 1, 2008

    Almac Clinical Services milestone achievement as full GMP compliance achieved across global sites

  • November 27, 2008

    Almac addresses leading cancer specialists at All-Ireland conference

  • October 10, 2008

    Almac Clinical Services Craigavon Facility Achieves Successful Inspection by MHRA

  • October 8, 2008

    Almac Group Staff Raise £7,000 for Local Charities

  • September 29, 2008

    Successful inspection by MHRA of Almac Clinical Services’ Pennsylvanian facility

  • September 18, 2008

    “Real potential of clinical technologies yet to be realized” says Almac

  • September 16, 2008

    Almac Diagnostics Launches Ovarian Cancer Research Tool

  • August 11, 2008

    Almac Donate $50,000 to Harleysville Area Emergency Medical Services

  • July 31, 2008

    Almac Announce World’s Largest Gene Expression Study To Develop Prognostic Test for Early Non Small Cell Lung Cancer

  • July 24, 2008

    Governor Rendell and Sir Allen McClay break ground at site of new Almac North American headquarters

  • July 2, 2008

    Almac Testers Receive ISTQB Software Testing Certification

  • June 27, 2008

    Almac Diagnostics Join Personalized Medicine Coalition

  • June 10, 2008

    Almac Group Launches Oncology Discovery Arm

  • May 20, 2008

    Almac Clinical Technologies signs contracts for a number of large, complex Clinical Trials

  • May 12, 2008

    WebEZ™ reaches a key milestone

  • May 8, 2008

    Almac Diagnostics in new deal to provide unique process to extract genetic information from Clinical Trial samples

  • March 31, 2008

    Almac Showcases Fully Integrated Suite of e-technologies at Partnerships with CROs and EDC & Beyond

  • March 20, 2008

    Almac Pharma Services Expands it Commercial Support Capability

  • March 17, 2008

    Almac appoints new VP Commercial Operations for Pharma Services

  • February 26, 2008

    Almac Inks 15-Year Deal with Affy to Secure Rights to Develop and Sell Array-Based Dxs

  • February 23, 2008

    The Power of Communication

  • February 21, 2008

    Almac Diagnostics Extends Agreement with Affymetrix

  • February 19, 2008

    Almac Expands Express Suite at DIA EuroMeeting

  • January 29, 2008

    Largest Ever Clinical Trials Cargo Shipped from Northern Ireland

  • January 28, 2008

    Almac: more US connections

  • January 11, 2008

    Almac & Merck to Present Adaptive Case Study at Upcoming Conference

  • December 18, 2007

    Almac wins top award at Tech Idol Showcase

  • December 5, 2007

    Almac Sciences: a global supply chain approach

  • December 5, 2007

    Almac Sciences: “First in man” approach to peptides

  • November 23, 2007

    Almac at the center of industry thinking

  • November 20, 2007

    BRCA1 Mutations Influence Cancer Cells’ Response to Drugs

  • October 23, 2007

    Almac to Build New US American Headquarters

  • October 16, 2007

    Almac Teams up with the Leukemia and Lymphoma Society

  • October 15, 2007

    Northern Ireland First Minister Commends Almac as a World Class Pharmaceutical Organisation

  • October 8, 2007

    Almac Clinical Technologies Hires New Director in San Francisco Office

  • September 11, 2007

    Recent Survey Results Praise Customer Service

  • August 28, 2007

    Almac’s Web Drug Reconciliation tool named finalist in GCPj awards

  • August 8, 2007

    Top of the Class for Almac Fundraisers

  • August 8, 2007

    Almac Diagnostics Announces Pioneering Genetic Research on Ductal Carcinoma In Situ (DCIS) Using Breast Cancer DSA™ Research Tool

  • August 6, 2007

    Sir Allen Interview Features in Belfast Telegraph’s “The Monday Interview”

  • July 31, 2007

    Almac Clinical Technologies Launches IXR Express: A new way for clients to accelerate the clinical trial process

  • July 25, 2007

    Almac present on Investigational Medicinal Products to leading Industry body

  • July 3, 2007

    Almac Clinical Services Feature in “The Big Question”

  • June 25, 2007

    Almac Group Highly Commended at NI Workplace and Employment Awards

  • June 20, 2007

    Almac Clinical Services to present at FDA Symposium at Harvard University.

  • May 31, 2007

    Almac Diagnostics Attends Pre-ide Meeting With FDA for Colorectal Cancer Diagnostic Derived from FFPE Tissue Craigavon, Northern Ireland, 28 May 2007

  • May 31, 2007

    Prof Patrick Johnston of Queen’s University Belfast & Almac Diagnostics honoured by President McAleese

  • May 23, 2007

    Almac Clinical Technologies speaks on ‘Quality’ at 43rd DIA Annual Meeting

  • May 17, 2007

    Latest iTrial EDC includes new PDF Audit Trail function

  • April 30, 2007

    Almac Launches New Innovative Clinical Supply Systems

  • April 27, 2007

    Almac Hosts Successful Clinical Supply Management Workshops across North America

  • April 19, 2007

    `Increase Role of Science in Schools’ says Almac Chairman

  • April 16, 2007

    Almac Diagnostics Announces Pioneering Genetic Research

  • March 16, 2007

    Sir Allen McClay: “Almac Leading The Way In Global Pharmaceutical Development”

  • March 9, 2007

    Almac Sciences Feature in “What Job Do You Do?”

  • March 9, 2007

    Almac Clinical Technologies At Top Clinical Trial Conferences

  • March 8, 2007

    Almac Sciences Invest In Edinburgh Facility

  • March 5, 2007

    Almac visit QUB to brief Pharmacists

  • February 14, 2007

    SafeBridge® Certification for Almac Sciences’ cytotoxics plant

  • February 14, 2007

    Almac Sciences and BioCatalytics Inc. to co-operate on key pharma products

  • February 14, 2007

    CPST fill-and-finish agreement for Almac Sciences’ cytotoxics

  • January 29, 2007

    Almac Clinical Technologies Appoints New Director of Business Development

  • January 22, 2007

    Almac distribution network now worldwide

  • December 29, 2006

    Almac Recruits Additional 250 Employees in NI in 2006

  • December 20, 2006

    Almac Clinical Technologies Spreading Holiday Cheer

  • December 19, 2006

    Diagnostics Multi Year License Agreement With GeneGo

  • December 18, 2006

    Almac Scoops Top UK Training Award

  • December 18, 2006

    Clinical Technologies Expands Its European Operations

  • December 5, 2006

    Almac Clinical Services Celebrates 10 Years in US

  • November 10, 2006

    Almac Pharma Services Extend Formulation Facilities

  • October 26, 2006

    Almac Hosts Science Development Day for Colleges

  • October 18, 2006

    Almac Clinical Services Scoops National Training Award

  • October 10, 2006

    Almac Sciences Scales Up for Peptides

  • September 29, 2006

    Almac Staff Raise Funds For Northern Ireland Charities

  • September 5, 2006

    Almac Clinical Technologies Celebrates Successful Launch of Drug Reconciliation Tool

  • August 17, 2006

    Clinical Services Continues Expansion with New Refrigerated Facility

  • August 10, 2006

    Clinical Services Expands Its Global Depot Network

  • June 19, 2006

    Pharma Companies Combine Under Almac Banner

  • May 22, 2006

    CTS Awarded Best Classroom Training Manual at 2006 PDA Biennial Training Conference

  • May 22, 2006

    ICTI Announces New President

  • May 4, 2006

    CTS Durham Undergoes EU-GMP Inspection From MHRA

  • April 25, 2006

    ICTI to Speak on Adaptive Trial Design at Brussels Conference

  • April 25, 2006

    CTS Host Successful Global Clinical Trial Distribution Workshops In The US

  • March 28, 2006

    Health Minister Visits Almac Sciences Facility

  • March 27, 2006

    ICTI Presents at DIAs 21st Clinical Data Management Symposium

  • March 22, 2006

    ICTI Implements Latest Version of MasterControl Training

  • March 21, 2006

    Almac Helps Governor Take Temperature Of NI Economy

  • March 20, 2006

    World Renown Cancer Specialists Visit Almac Sciences

  • March 20, 2006

    PDMS Extend Formulation Development Facility

  • March 9, 2006

    Eirx Therapeutic Plc & Diagnostics Agreement

  • February 16, 2006

    CSS Radio Goes Live; Chiral Building Blocks Range Announced

  • February 13, 2006

    Sir Allen McClay Opens New £1.25 million Laboratory of Biology Chemistry at Queens

  • February 3, 2006

    CTS Announce Agenda for Clinical Trial Distribution Workshops

  • January 24, 2006

    ICTI Biostatistics Expert speaks at International Conference

  • January 11, 2006

    Almac Diagnostics Receives ISO17025 Accreditation

  • January 10, 2006

    ICTI Expands European Operations

  • January 10, 2006

    ArraDx Joins Almac Sciences – Now Almac Diagnostics

  • January 9, 2006

    Dr Allen McClay, CBE Receives Knighthood in New Year’s Honours List

  • December 23, 2005

    ICTI Completes Implementation of Tech-Support Software: IncidentMonitor TM

  • November 29, 2005

    CSS Focuses on Australian Market

  • November 25, 2005

    CSS Launches Global Provision of Radiolabelling Services

  • September 21, 2005

    ICTI software used in major Government Study

  • September 14, 2005

    ICTI Expert Hosts Roundtable at FDA Conference

  • July 19, 2005

    ICTI Biostatistics Expert speaks at International Conference

  • June 23, 2005

    ICTI Increase Drug Study Management Efficiency

  • May 9, 2005

    PDMS Awards Major Pharmaceuticals Manufacturing System Contract to SSI

  • May 5, 2005

    ICTI Announce Successful Implementation of a SAN

  • April 21, 2005

    ICTI Marks Milestone for EDC

  • March 9, 2005

    ICTI Acquires Leading EDC Software

  • March 4, 2005

    CSS Albachem Secures a Share of £3.7 million R&D Programme

  • December 21, 2004

    Chiral Consortium

  • December 7, 2004

    CSS Enters Chiral Market Through Collaborations with ChiralQuest and IEP

  • December 7, 2004

    CSS Expands Capability in Specialist Manufacturing

  • October 28, 2004

    CSS Launches Unique Consortium at CPhI

  • August 23, 2004

    Company Name Change

  • May 10, 2004

    CSS Acquires Controlling Interest in Peptide Company ALBACHEM

  • December 2, 2003

    Almac Sciences acquire PDMS

  • September 1, 2003

    Senator GEORGE MITCHELL Officially Opens New CSS Facility